Hot Flash: FDA places Wyeth profits above well-being of women (US)

It’s All about the Estriol

Written by JADED MARE

Wyeth logo.

The mega drug company that serves tens of thousands of women ovarian cancer, lupus, scleroderma, gallbladder cancer, stroke, breast cancer, blood clots and deafness as side dishes to their hormone replacement therapy diet of drugs [Premarin(R), Prempro(R), Premphase(R)] derived from urine milked from pregnant horses], filed a “citizen petition” before the perilously unreliable government agency, the US Food and Drug Administration (FDA — you know, the ones who didn’t know where that salmonella came from until months of searching everybody’s salsa), to pretty much ban the use of Estriol in the USA … and what a surprise, won.

Yes, that would be Wyeth Pharmaceuticals, the proud peddlers of Premarin(R) and Prempro(R) since the 50’s resulting in the displacement and subsequent death of the innocent living, feeling byproducts used to make its change of life meds, namely thousands of mares and foals.

Seems that a bunch of docs and other medical types were none too happy about it. Back in January of this year, Elixir News wrote:

A coalition of gynecologists, internists, allergists, ER physicians and general practitioners responsible for treating thousands of women today criticized the US’s Food and Drug Administration (FDA) for taking action that threatens to deny hundreds of thousands of women access to customized medications they take for symptoms of menopause.

The FDA last week announced that the hormone Estriol can no longer be used in estrogen medications customized for women by compounding pharmacies. Estriol is a component of 90 percent or more of these customized preparations.

The FDA action is in response to a “citizen petition” filed by the giant drug maker Wyeth Pharmaceuticals. Wyeth is the maker of Premarin and Prempro, two hormone treatments for women that have been linked to cancer, heart disease and stroke by a 2002 Women’s Health Initiative, National Institute of Health (NIH) study. Millions of women have discontinued taking Wyeth’s hormone products as a result of the WHI study, which was halted because of the serious health risks that were discovered in 2002.

“The FDA has succumbed to pressure from Wyeth in its attempt to clear the market of safer alternatives to its unsafe products,” said Erika Schwartz, M.D., a co-founder of BHI, the Bioidentical Hormone Initiative, a not-for-profit medical organization comprised of conventionally trained, practicing physicians who have successfully treated patients with bioidentical hormones for years. “The FDA should protect the interest of women, not the profits of Wyeth.”

:: Emphasis added.

Dr. Frank Comstock of Tuscon, Arizona opined:

When Wyeth petitioned the FDA to restrict patients’ access to alternatives to its [Wyeth Pharma] products, more than 70,000 patients and doctors filed comments in response – the vast majority of whom opposed Wyeth’s request.

Here’s what NaturalNews tell us now about this bit of FDA-Wyeth head bumping:

The FDA has issued a warning letter to seven pharmacies, instructing them to stop claiming that “bio-identical hormone replacement therapy” (BHRT) is different or safer than conventional hormone replacement therapy (HRT), and to stop selling prescriptions for an unapproved hormone.

The warning came in response to a petition from pharmaceutical giant Wyeth, in addition to concerns expressed by health-care companies and consumer groups.

“Many pharmacy compounders use the term bio-identical to imply that their drugs are natural,” said Deborah M. Autor, director of the FDA Center for Drug Evaluation and Research’s Office of Compliance. “There is no creditable scientific support for this claim.”

The agency warned that the pharmacies, mostly online retailers, might face drug seizures or other sanctions if they do not correct their practices. The agency noted that with the exception of compound drugs containing estriol, which is not approved for U.S. use, the sale of BHRT drugs is not illegal.

Hey, guess what? According to Pharmalot.com, Wyeth-Pharma sells two types of Estriol drugs in Europe, so this is not a safety and efficacy issue.

Buy Not? Take Not?

We would not do anything like incite you to boycott Wyeth Pharmaceutical products. We will leave it up to you, armed with the above information, on whether or not you want to do business with them, or have any of the women in your life take their hormone replacement therapy drugs.

Here are just some of the most common drugs from the list of 75 Wyeth Family of Products on its website:

Advil (R)
Anbesol (R)
Caltrate(R)
Centrum (R)
Chapstick(R)
Dimetapp(R)
Dristan(R)
Norplant (R)
Pinnacle IN (R) – Equine Strangles
Premarin (R)
Prempro (R)
Premphrase (R)
Preparation H (R)
QUEST Gel (R) – Equine Internal Parasites
Robitussin (R)

—————-

RELATED READING

:: Wyeth faces more than more than 5,000 lawsuits over menopause drugs, still on the market

:: U.S. breast cancer rate falls 7 percent after HRT drug use drops